These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 17327375

  • 1. Fasting hyperglycemia impairs glucose- but not insulin-mediated suppression of glucagon secretion.
    Abdul-Ghani M, DeFronzo RA.
    J Clin Endocrinol Metab; 2007 May; 92(5):1778-84. PubMed ID: 17327375
    [Abstract] [Full Text] [Related]

  • 2. Postprandial serum C-peptide to plasma glucose concentration ratio correlates with oral glucose tolerance test- and glucose clamp-based disposition indexes.
    Okuno Y, Komada H, Sakaguchi K, Nakamura T, Hashimoto N, Hirota Y, Ogawa W, Seino S.
    Metabolism; 2013 Oct; 62(10):1470-6. PubMed ID: 23831440
    [Abstract] [Full Text] [Related]

  • 3. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E, Menschikowski M, Koehler C, Leonhardt W, Hanefeld M.
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [Abstract] [Full Text] [Related]

  • 4. Impaired Suppression of Glucagon in Obese Subjects Parallels Decline in Insulin Sensitivity and Beta-Cell Function.
    Chen X, Maldonado E, DeFronzo RA, Tripathy D.
    J Clin Endocrinol Metab; 2021 Apr 23; 106(5):1398-1409. PubMed ID: 33524152
    [Abstract] [Full Text] [Related]

  • 5. Chronic physiologic hyperglycemia impairs insulin-mediated suppression of plasma glucagon concentration in healthy humans.
    Chen X, Merovci A, DeFronzo RA, Tripathy D.
    Metabolism; 2023 May 23; 142():155512. PubMed ID: 36746320
    [Abstract] [Full Text] [Related]

  • 6. Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.
    Knop FK, Aaboe K, Vilsbøll T, Vølund A, Holst JJ, Krarup T, Madsbad S.
    Diabetes Obes Metab; 2012 Jun 23; 14(6):500-10. PubMed ID: 22171657
    [Abstract] [Full Text] [Related]

  • 7. Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects.
    Hansen KB, Vilsbøll T, Bagger JI, Holst JJ, Knop FK.
    J Clin Endocrinol Metab; 2010 Jul 23; 95(7):3309-17. PubMed ID: 20410219
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Increment of serum C-peptide measured by glucagon test closely correlates with human relative beta-cell area.
    Fujita Y, Kozawa J, Iwahashi H, Yoneda S, Uno S, Yoshikawa A, Okita K, Eguchi H, Nagano H, Imagawa A, Shimomura I.
    Endocr J; 2015 Jul 23; 62(4):329-37. PubMed ID: 25740613
    [Abstract] [Full Text] [Related]

  • 10. Examining the effects of hyperglycemia on pancreatic endocrine function in humans: evidence for in vivo glucotoxicity.
    Solomon TP, Knudsen SH, Karstoft K, Winding K, Holst JJ, Pedersen BK.
    J Clin Endocrinol Metab; 2012 Dec 23; 97(12):4682-91. PubMed ID: 23043193
    [Abstract] [Full Text] [Related]

  • 11. Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies.
    Bonora E, Moghetti P, Zancanaro C, Cigolini M, Querena M, Cacciatori V, Corgnati A, Muggeo M.
    J Clin Endocrinol Metab; 1989 Feb 23; 68(2):374-8. PubMed ID: 2645308
    [Abstract] [Full Text] [Related]

  • 12. Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose.
    Abdul-Ghani MA, Williams K, DeFronzo R, Stern M.
    Diabetes Care; 2006 Jul 23; 29(7):1613-8. PubMed ID: 16801587
    [Abstract] [Full Text] [Related]

  • 13. [Critical evaluation of the oral glucose tolerance test for the diagnosis of insulin resistance in patients with polycystic ovary syndrome].
    Calvar CE, Bengolea SV, Hermes R, Loyato M.
    Medicina (B Aires); 2007 Jul 23; 67(1):1-7. PubMed ID: 17408014
    [Abstract] [Full Text] [Related]

  • 14. Inappropriate glucagon response after oral compared with isoglycemic intravenous glucose administration in patients with type 1 diabetes.
    Hare KJ, Vilsbøll T, Holst JJ, Knop FK.
    Am J Physiol Endocrinol Metab; 2010 Apr 23; 298(4):E832-7. PubMed ID: 20103744
    [Abstract] [Full Text] [Related]

  • 15. Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action.
    Gutniak M, Grill V, Efendić S.
    J Clin Endocrinol Metab; 1986 Jan 23; 62(1):77-83. PubMed ID: 2866196
    [Abstract] [Full Text] [Related]

  • 16. Role of GLP-1 induced glucagon suppression in type 2 diabetes mellitus.
    Hare KJ.
    Dan Med Bull; 2010 Sep 23; 57(9):B4181. PubMed ID: 20816021
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.
    Gerich JE, Langlois M, Noacco C, Lorenzi M, Karam JH, Korsham PH.
    J Clin Invest; 1976 Aug 23; 58(2):320-5. PubMed ID: 783198
    [Abstract] [Full Text] [Related]

  • 18. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
    Ozeki N, Hara K, Yatsuka C, Nakano T, Matsumoto S, Suetsugu M, Nakamachi T, Takebayashi K, Inukai T, Haruki K, Aso Y.
    Metabolism; 2009 Oct 23; 58(10):1470-6. PubMed ID: 19592051
    [Abstract] [Full Text] [Related]

  • 19. Postprandial hyperglycemia and pancreatic function in cystic fibrosis patients.
    Hinds A, Sheehan AG, Machida H, Parsons HG.
    Diabetes Res; 1991 Oct 23; 18(2):69-78. PubMed ID: 1841815
    [Abstract] [Full Text] [Related]

  • 20. Hyperglycemia and obesity as determinants of glucose, insulin, and glucagon responses to beta-endorphin in human diabetes mellitus.
    Giugliano D, Salvatore T, Cozzolino D, Ceriello A, Torella R, D'Onofrio F.
    J Clin Endocrinol Metab; 1987 Jun 23; 64(6):1122-8. PubMed ID: 2952663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.